POST Online Media Lite Edition



 

NEWLY REPORTED COVID-19 CASES (11.19.2021, 4:50pm CEST, WHO):   India 11,106    Brazil 11,977    United Kingdom 46,858    Russia 37,156    Turkey 22,234    France 19,840    Argentina 1,553    Germany 52,970    Spain 3,932    Columbia 2,257    Italy 10,645    Mexico 3,836    Ukraine 20,050    Poland 23,242    Philippines 1,297    Malaysia 6,380    Netherlands 23,680    Peru 1,370    Thailand 6,855    Czechia 13,374    Canada 2,448    Romania 3,076    Chile 2,611    Serbia 3,219    Sweden 1,210    Portugal 2,398    Vietnam 10,223    Kazakhstan 1,272    Austria 14,212    Hungary 11,289    Greece 7,276    Georgia 4,278    Bulgaria 2,785    Belarus 1,844    Slovakia 7,418    Azerbaijan 2,124    Croatia 7,270    Bolivia 1,119    Ireland 4,646    Lithuania 1,847    Denmark 4,013    South Korea 3,034    Slovenia 3,662    Latvia 1,221    Laos 1,401    China 31    New Zealand 200    Australia 1,302   

Doctors in South Korea successfully detect cancer cells in blood

Staff Writer |
A group of South Korean doctors discovered a method to successfully detect cancer cells within a small blood sample, the state-run cancer institute said.

Article continues below






This is a discovery that could lead to a broad range of practical clinical applications in the diagnosis and treatment of cancer.

The team led by Cho Young-koo at the National Cancer Center successfully detected and isolated circulating tumor cells (CTC) in blood samples of early-stage breast cancer patients.

CTCs have been recognized as promising biomarkers for diagnosis and indication of several cancers. However, CTC monitoring at present is available only for advanced-stage patients rather than for those in an early stage.

The researchers developed a method using magnetic nanowires to aid in the efficient isolation and detection of CTCs in the blood of patients, especially those with early-stage cancers, the institute said.

"The detection of CTCs will greatly help not only the early diagnosis of cancer but also in treatment," said Cho, adding that the technology involves just simply drawing blood from patients not a biopsy.


What to read next

Low-cost blood test could be key weapon against No. 4 cancer killer in U.S.
Researchers find how cancer cells may become resistant to drugs
Leukaemia - The Introduction